261 related articles for article (PubMed ID: 9636501)
1. Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach.
Turner CD; Bruce DS; Cronin DC; Loss GE; Grewal H; Siegel C; Millis JM; Newell KA; Davis B; Todo T; Thistlethwaite JR; Woodle ES
Transplant Proc; 1998 Jun; 30(4):1234-5. PubMed ID: 9636501
[No Abstract] [Full Text] [Related]
2. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
[No Abstract] [Full Text] [Related]
3. Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation.
Kliem V; Radermacher J; Hiss M; Pethig M; Burg M; Brunkhorst R
Transplant Proc; 1999 Nov; 31(7A):37S-40S. PubMed ID: 10576041
[No Abstract] [Full Text] [Related]
4. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
[TBL] [Abstract][Full Text] [Related]
5. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
[No Abstract] [Full Text] [Related]
6. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H
Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
[No Abstract] [Full Text] [Related]
7. Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal.
Cronin DC; Bruce DS; Newell KA; Josephson MA; Millis JM; Piper JB; Ruebe M; Kirby M; Thistlethwaite JR; Woodle ES
Transplant Proc; 1997; 29(1-2):307. PubMed ID: 9123010
[No Abstract] [Full Text] [Related]
8. Tacrolimus rescue therapy for renal allograft rejection refractory to cyclosporine-based immunosuppression.
Washburn WK; Shaffer D; Simpson MA; Conway P; Madras PN; Monaco AP
Transplant Proc; 1996 Apr; 28(2):1015-6. PubMed ID: 8623214
[No Abstract] [Full Text] [Related]
9. Tacrolimus for rescue therapy in refractory renal allograft rejection.
Jang HJ; Kim SC; Han DJ
Transplant Proc; 2000 Nov; 32(7):1765-6. PubMed ID: 11119925
[No Abstract] [Full Text] [Related]
10. Five-year experience with tacrolimus rescue for renal allograft rejection.
Jordan ML; Naraghi RN; Shapiro R; Smith D; Vivas CA; Scantlebury VP; Gritsch HA; McCauley J; Randhawa P; Demetris AJ; McMichael J; Fung JJ; Starzl TE
Transplant Proc; 1997; 29(1-2):306. PubMed ID: 9123009
[No Abstract] [Full Text] [Related]
11. FK506 rescue therapy for acute renal allograft rejection.
Goh BL; Morad Z; Cheah PL; Chua CT; Tan SY
Transplant Proc; 1998 Nov; 30(7):3592-3. PubMed ID: 9838574
[No Abstract] [Full Text] [Related]
12. Acute rejection and the therapeutic choice of drug.
Ichikawa Y; Nojima M; Kyo M; Yazawa K; Hanafusa T; Ebisui C; Tsubakihara Y; Fukunishi T; Nagano S
Transplant Proc; 2000 Nov; 32(7):1759-60. PubMed ID: 11119923
[No Abstract] [Full Text] [Related]
13. Excellent long-term survival of low-risk, first renal allografts using cyclosporine/azathioprine double therapy.
Faull RJ; Bannister KM; Russ GR; Mathew TH; Clarkson AR
Transplant Proc; 1999; 31(1-2):1155-6. PubMed ID: 10083516
[No Abstract] [Full Text] [Related]
14. Tacrolimus rescue therapy in late rejection after renal transplantation: outcome after 18 months.
Budde K; Fritsche L; Smettan S; Schönberger B; Loening SA; Mai I; Bauer S; Waiser J; Neumayer HH
Transplant Proc; 1998 Jun; 30(4):1238-9. PubMed ID: 9636503
[No Abstract] [Full Text] [Related]
15. OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection.
Patschan D; Kribben A; Pietruck F; Lutz J; Binek M; Philipp T; Heemann U; Witzke O
Nephron Clin Pract; 2006; 103(3):c94-9. PubMed ID: 16534238
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group.
Jensik SC
Transplant Proc; 1998 Jun; 30(4):1216-8. PubMed ID: 9636494
[No Abstract] [Full Text] [Related]
18. Tacrolimus for rescue of refractory renal allograft rejection.
Jordan ML; Naraghi R; Shapiro R; Smith D; Vivas CA; Scantlebury VP; Gritsch HA; McCauley J; Randhawa P; Demetris AJ; McMichael J; Fung JJ; Starzl TE
Transplant Proc; 1998 Jun; 30(4):1257-60. PubMed ID: 9636511
[No Abstract] [Full Text] [Related]
19. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
Wong KM; Cheung CY; Chan YH; Chak WL; Choi KS; Chau KF; Li CS
Transplant Proc; 2000 Nov; 32(7):1721-2. PubMed ID: 11119907
[No Abstract] [Full Text] [Related]
20. Graft outcome in patients with biopsy-proven chronic renal allograft rejection.
Peddi VR; Schroeder TJ; Weiskittel P; First MR
Transplant Proc; 1999; 31(1-2):1308-9. PubMed ID: 10083584
[No Abstract] [Full Text] [Related]
[Next] [New Search]